Timken India Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Timken India Limited has scheduled a conference call to discuss its 1Q FY27 financial performance on August 5, 2026.
BSE & NSE corporate filings with AI summaries
Timken India Limited
Timken India Limited has scheduled a conference call to discuss its 1Q FY27 financial performance on August 5, 2026.
Oriental Aromatics Limited
Oriental Aromatics Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with a net profit of ₹815.32 crore and ₹251.42 crore for standalone and consolidated financials, respectively. The company has also appointed Mr. Nitin Bhuduvalekar as Vice President - Sales Fragrance, effective July 30, 2026.
Balkrishna Industries Limited
Balkrishna Industries Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on July 29, 2026, and informed the Exchange regarding voting results.
Navin Fluorine International Limited
Navin Fluorine International Limited has scheduled an earnings call to discuss its Q1 FY 2026-27 financial performance on August 5, 2026.
Rainbow Childrens Medicare Limited
Rainbow Children's Medicare Limited has informed the Exchange about the grant of 2,570 stock options to Mr. Anshuman Jaiswal under the Employee Stock Option Scheme 2025. The options are exercisable into 2,570 equity shares with a face value of ₹ 10/- each, fully paid-up. The exercise price is determined at a discount of not more than 20% on the latest available closing price of the Company's equity shares on the National Stock Exchange of India Limited (NSE). The vested stock options shall be exercisable within a period of maximum of 2 (Two) years from the date of each vesting.
Satin Creditcare Network Limited
Satin Creditcare Network Limited has announced its Q1 FY27 financial results, reporting a consolidated PAT of ₹123 Crores, a 172% YoY increase, and a 20th consecutive profitable quarter. The company's assets under management grew 27.5% YoY to ₹15,935 Crores, and disbursements increased 55.9% YoY to ₹3,495 Crores. The company has also reported a marginal cost of borrowing reduction of 37 bps YoY to 10.52% and a credit cost of 3.06%, excluding a management overlay buffer of ₹36 Crores.
De Nora India Limited
De Nora India Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, which were reviewed and approved by the Audit Committee and the Board of Directors. The results show a profit before tax of ₹859.89 lakh and a profit after tax of ₹638.96 lakh. The company has also approved the appointment of a Cost Auditor for the financial year 2026-27 and has disclosed a material related party transaction with Industrie De Nora S.p.A., Italy.
Paradeep Phosphates Limited
Paradeep Phosphates Limited has released its Q1 FY27 earnings presentation, highlighting a 36% YoY increase in revenue from operations to ₹ 6,124 crore, a 21% YoY rise in EBITDA to ₹ 742 crore, and a 24% YoY increase in PBT to ₹ 526 crore. Sales volume grew by 4% to 9.85 LMT. The company has also announced plans to set up an Aluminum Fluoride (AlF3) Plant at Paradeep with an investment of ₹ 250 Cr.
Macpower CNC Machines Limited
Macpower CNC Machines Limited has published un-audited financial results for the quarter ended June 30, 2026, in accordance with SEBI regulations.
Gammon India Limited
Gammon India Limited has informed the Exchange regarding Outcome of Board Meeting held on July 30, 2026. The Board approved the draft notice of the upcoming Annual General Meeting (AGM) and the cut-off date for E-Voting.
Maral Overseas Limited
Maral Overseas Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, along with the Limited Review Report issued by the Statutory Auditors. The Board of Directors has also approved the extension of the timeline for the acquisition of an equity stake in Asawata Energy Private Limited by six months.
Maral Overseas Limited
Maral Overseas Limited has informed the Exchange about General Updates, including the outcome of the Board Meeting held on 30th July 2026. The Board considered and approved the unaudited financial results for the quarter ended 30th June 2026, along with the Limited Review Report issued by the Statutory Auditors. Additionally, the Board approved the extension of the timeline for the acquisition of a 26% equity stake in Asawata Energy Private Limited by a further period of 6 months.
Max Healthcare Institute Limited
Max Healthcare Institute Limited held its 25th Annual General Meeting on July 30, 2026, through video conference, in compliance with regulatory circulars. The meeting was attended by directors, senior management personnel, and other representatives. The quorum was met with 160 members present.
Banaras Beads Limited
Banaras Beads Limited held its 46th Annual General Meeting on July 30, 2026, through physical mode. The meeting was attended by 67 shareholders, including 5 promoters and 62 public shareholders. The quorum was present, and the meeting was conducted by Mr. Ashok Kumar Gupta, Chairman and Managing Director. The proceedings included speeches by the Chairman, CEO, and Company Secretary, as well as discussions on future prospects and business strategy. The meeting also included the scrutiny of votes cast through remote e-voting and ballot.
Torrent Pharmaceuticals Limited
Torrent Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 30, 2026, titled 'A Press Release on Financial Results which is being submitted to the media is also enclosed herewith as an Annexure B.' The company has approved its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, and will publish an extract of the unaudited consolidated financial results. Ameera Shah will be completing her term as an Independent Director of the Company on August 1, 2026.
Ujaas Energy Limited
Ujaas Energy Limited has announced its unaudited financial results for the quarter ended June 30, 2026, and has also reconstituted its Corporate Social Responsibility (CSR) Committee and Nomination and Remuneration Committee (NRC).
Torrent Pharmaceuticals Limited
Torrent Pharmaceuticals Limited has announced its unaudited financial results for the quarter ended 30-Jun-26, with the Board approving the results and a limited review report by BS R & Co. LLP. The company also announced that Ameera Shah will be completing her term as an Independent Director on 01-Aug-26.
LEEL Electricals Limited
LEEL Electricals Limited has informed the Exchange regarding 'Intimation under regulation 76 of SEBI (Depositories & Participants) Regulation, 2018 for the quarter ending on 30.06.2026. The company has initiated liquidation proceedings against itself, and the liquidator has issued a sale certificate for the sale of the company as a going concern. The new management was inducted on the board of the entity w.e.g. 01.07.2024, and the necessary intimations were given to the Stock Exchanges. The company has undergone capital restructuring, including the cancellation and extinguishment of the existing equity share capital of the promoters/promoters group and the reduction of the equity share capital of the public shareholders.
Vardhman Textiles Limited
Vardhman Textiles Limited has informed the Exchange about Investor Presentation, disclosing its un-audited financial results for the quarter ended June 30, 2026, as part of its compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Hester Biosciences Limited
Hester Biosciences Limited has informed the Exchange about the link of recording of the earnings conference call on the financial results for the quarter ended 30 June 2026.